SABSW:NASDAQ
SAB Biotherapeutics
$0.019
arrow_upward
+35.71%(+0.0050) 1D
$0.014
arrow_downward
-25.26% (-0.0048)bedtimeAfter hours
Closed: Sep 11, 4:00:00 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SABSW...
Open
$0.02
High
$0.04
Low
$0.02
Mkt. cap
310.26M
Avg. vol.
161.29K
Volume
47.60K
52-wk high
$0.20
52-wk low
$0.00
Beta
0.86
No. of employees
86
Open
$0.02
High
$0.04
Low
$0.02
Mkt. cap
310.26M
Avg. vol.
161.29K
Volume
47.60K
52-wk high
$0.20
52-wk low
$0.00
Beta
0.86
No. of employees
86
News stories
From web sources and news partners
https://www.dars.gov.et/
·
3 months ago
SABS Q1 2026 Earnings: EPS Misses Estimates as Clinical-Stage Biotech Advances Pipeline - Post-Announcement Reaction
About SAB Biotherapeutics
CEO-
Employees86
Founded2014
HeadquartersMiami Beach, Florida, United States
SectorBiotechnology
Websitesab.bio